Influenza Vaccine in Pregnancy Part 2

This study has been completed.
Sponsor:
Information provided by:
St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier:
NCT00593970
First received: January 3, 2008
Last updated: April 14, 2010
Last verified: November 2009
  Purpose

Pregnant women have limited knowledge regarding influenza, its implications during pregnancy, and recommendations for vaccination during pregnancy. The researchers plan to distribute an information pamphlet to women in a prenatal clinic, offer the vaccine during prenatal visits, and then give a questionnaire on the postpartum floor assessing knowledge.

The researchers hypothesize that with education intervention, knowledge scores on the questionnaire will be higher than those from last year, when no education was provided.


Condition
Influenza
Pregnancy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Knowledge Possessed by Pregnant Women Regarding Influenza Vaccination During Pregnancy

Resource links provided by NLM:


Further study details as provided by St. Michael's Hospital, Toronto:

Primary Outcome Measures:
  • Knowledge scores on our questionnaire [ Time Frame: 2 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 250
Study Start Date: November 2007
Study Completion Date: January 2008
Groups/Cohorts
1
All women presenting to our prenatal clinic and postpartum floor during the study period.

  Eligibility

Ages Eligible for Study:   14 Years to 46 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

A multi-ethnic group of pregnant women

Criteria

Inclusion Criteria:

  • all pregnant women

Exclusion Criteria:

  • known hypersensitivity to influenza vaccine
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00593970

Locations
Canada, Ontario
St. Michael's Hospital
Toronto, Ontario, Canada, M5B1W8
Sponsors and Collaborators
St. Michael's Hospital, Toronto
Investigators
Principal Investigator: Mark H Yudin, MD St. Michael's Hospital, Toronto
  More Information

No publications provided

Responsible Party: Mark H Yudin, MD, St. Michael's Hospital
ClinicalTrials.gov Identifier: NCT00593970     History of Changes
Other Study ID Numbers: REB 06-190part2
Study First Received: January 3, 2008
Last Updated: April 14, 2010
Health Authority: Canada: Ethics Review Committee

Keywords provided by St. Michael's Hospital, Toronto:
influenza
vaccine
pregnancy

Additional relevant MeSH terms:
Influenza, Human
Orthomyxoviridae Infections
RNA Virus Infections
Virus Diseases
Respiratory Tract Infections
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on September 18, 2014